Developing antiviral treatments for specific RNA viruses that could cause pandemics
DEVELOPMENT OF ANTIVIRALS FOR SPECIFIC RNA VIRAL FAMILIES OF PANDEMIC POTENTIAL
This study is working on a new antiviral treatment that could help fight off certain viruses that might cause pandemics, and it aims to make this medicine available for patients when they need it most.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arisan Therapeutics, INC. NIH-funded |
| Lab location | 1 site (Carlsbad, UNITED STATES) |
| Project ID | NIH-10933177 on NIH RePORTER |
What this research studies
This research focuses on advancing a promising antiviral treatment aimed at specific RNA viruses with the potential to cause pandemics. The project involves a series of development activities, including preclinical testing, optimization of the drug's chemistry, and ensuring that the manufacturing processes meet regulatory standards. Patients may benefit from the eventual availability of effective antiviral therapies that can be deployed during future pandemic outbreaks.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk of exposure to RNA viruses with pandemic potential.
Not a fit: Patients who are not at risk of exposure to these specific RNA viruses may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective antiviral treatments that protect patients during pandemic outbreaks.
How similar studies have performed: Other research has shown success in developing antiviral treatments for viral infections, indicating that this approach has potential.
Where this research is happening
Carlsbad, UNITED STATES
- Arisan Therapeutics, INC. — Carlsbad, United States (Active)
Researchers
- Principal investigator: Henkel, Greg — Arisan Therapeutics, INC.
- Study coordinator: Henkel, Greg
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.